Recent developments in immunotoxin therapy

Maria Ana Ghetie, Ellen S. Vitetta

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Immunotoxin (IT) research has been ongoing for 15 years. During the past 2 years, work has focused on several areas: on improvements and developments in first- and second-generation ITs; the preparation of new immunotoxin constructs with anti-tumor activity; novel animal models for preclinical evaluation of immunotoxins; and clinical trials, which are now entering Phase II or III in humans.

Original languageEnglish (US)
Pages (from-to)707-714
Number of pages8
JournalCurrent Opinion in Immunology
Volume6
Issue number5
DOIs
StatePublished - 1994

Fingerprint

Immunotoxins
Therapeutics
Animal Models
Clinical Trials
Research
Neoplasms

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Recent developments in immunotoxin therapy. / Ghetie, Maria Ana; Vitetta, Ellen S.

In: Current Opinion in Immunology, Vol. 6, No. 5, 1994, p. 707-714.

Research output: Contribution to journalArticle

Ghetie, Maria Ana ; Vitetta, Ellen S. / Recent developments in immunotoxin therapy. In: Current Opinion in Immunology. 1994 ; Vol. 6, No. 5. pp. 707-714.
@article{bf5da3c2d06f4889819cd82c474eb808,
title = "Recent developments in immunotoxin therapy",
abstract = "Immunotoxin (IT) research has been ongoing for 15 years. During the past 2 years, work has focused on several areas: on improvements and developments in first- and second-generation ITs; the preparation of new immunotoxin constructs with anti-tumor activity; novel animal models for preclinical evaluation of immunotoxins; and clinical trials, which are now entering Phase II or III in humans.",
author = "Ghetie, {Maria Ana} and Vitetta, {Ellen S.}",
year = "1994",
doi = "10.1016/0952-7915(94)90073-6",
language = "English (US)",
volume = "6",
pages = "707--714",
journal = "Current Opinion in Immunology",
issn = "0952-7915",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Recent developments in immunotoxin therapy

AU - Ghetie, Maria Ana

AU - Vitetta, Ellen S.

PY - 1994

Y1 - 1994

N2 - Immunotoxin (IT) research has been ongoing for 15 years. During the past 2 years, work has focused on several areas: on improvements and developments in first- and second-generation ITs; the preparation of new immunotoxin constructs with anti-tumor activity; novel animal models for preclinical evaluation of immunotoxins; and clinical trials, which are now entering Phase II or III in humans.

AB - Immunotoxin (IT) research has been ongoing for 15 years. During the past 2 years, work has focused on several areas: on improvements and developments in first- and second-generation ITs; the preparation of new immunotoxin constructs with anti-tumor activity; novel animal models for preclinical evaluation of immunotoxins; and clinical trials, which are now entering Phase II or III in humans.

UR - http://www.scopus.com/inward/record.url?scp=0028148350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028148350&partnerID=8YFLogxK

U2 - 10.1016/0952-7915(94)90073-6

DO - 10.1016/0952-7915(94)90073-6

M3 - Article

VL - 6

SP - 707

EP - 714

JO - Current Opinion in Immunology

JF - Current Opinion in Immunology

SN - 0952-7915

IS - 5

ER -